Page last updated: 2024-10-30

nordefrin and Glycogen Storage Disease Type II

nordefrin has been researched along with Glycogen Storage Disease Type II in 1 studies

Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.

Glycogen Storage Disease Type II: An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)

Research Excerpts

ExcerptRelevanceReference
"Pompe's disease is an autosomal recessive and often fatal condition, caused by mutations in the acid alpha-glucosidase gene, leading to lysosomal glycogen storage in heart and skeletal muscle."1.31Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice. ( Duncker, DJ; Kamphoven, JH; Reuser, AJ; Stubenitsky, R; Van Der Ploeg, AT; Verdouw, PD, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamphoven, JH1
Stubenitsky, R1
Reuser, AJ1
Van Der Ploeg, AT1
Verdouw, PD1
Duncker, DJ1

Other Studies

1 other study available for nordefrin and Glycogen Storage Disease Type II

ArticleYear
Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice.
    Physiological genomics, 2001, Apr-27, Volume: 5, Issue:4

    Topics: alpha-Glucosidases; Anesthetics, Inhalation; Animals; Cardiomyopathy, Hypertrophic; Dobutamine; Gluc

2001